BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 8051547)

  • 1. Accurate differentiation of neuronopathic and nonneuronopathic forms of Niemann-Pick disease by evaluation of the effective residual lysosomal sphingomyelinase activity in intact cells.
    Graber D; Salvayre R; Levade T
    J Neurochem; 1994 Sep; 63(3):1060-8. PubMed ID: 8051547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation of fluorescent and radiolabelled sphingomyelins in intact cells by a non-lysosomal pathway.
    Levade T; Vidal F; Vermeersch S; Andrieu N; Gatt S; Salvayre R
    Biochim Biophys Acta; 1995 Oct; 1258(3):277-87. PubMed ID: 7548198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingomyelinase and nonspecific phosphodiesterase activities in Epstein-Barr virus-transformed lymphoid cell lines from Niemann-Pick disease A, B and C.
    Levade T; Salvayre R; Lenoir G; Douste-Blazy L
    Biochim Biophys Acta; 1984 Apr; 793(2):321-4. PubMed ID: 6324871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New tools for the study of Niemann-Pick disease: analogues of natural substrate and Epstein-Barr virus-transformed lymphoid cell lines.
    Levade T; Salvayre R; Bes JC; Nezri M; Douste-Blazy L
    Pediatr Res; 1985 Jan; 19(1):153-7. PubMed ID: 2982124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for both endogenous and exogenous sources of the sphingomyelin storage in lymphoid cell lines from patients with Niemann-Pick disease types A and B.
    Levade T; Salvayre R; Maret A; Douste-Blazy L
    J Inherit Metab Dis; 1988; 11(2):151-7. PubMed ID: 3139926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular forms of sphingomyelinase and non-specific phosphodiesterases in Epstein-Barr virus-transformed lymphoid cell lines from Niemann-Pick disease types A and B.
    Levade T; Salvayre R; Douste-Blazy L
    Eur J Biochem; 1985 Jun; 149(2):405-9. PubMed ID: 2986976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different pathways of uptake and degradation of sphingomyelin by lymphoblastoid cells and the potential participation of the neutral sphingomyelinase.
    Levade T; Gatt S; Maret A; Salvayre R
    J Biol Chem; 1991 Jul; 266(21):13519-29. PubMed ID: 1649823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Niemann-Pick disease, Type C: evidence for the deficiency of an activating factor stimulating sphingomyelin and glucocerebroside degradation.
    Christomanou H
    Hoppe Seylers Z Physiol Chem; 1980 Oct; 361(10):1489-502. PubMed ID: 6256275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ assay of acid sphingomyelinase and ceramidase based on LDL-mediated lysosomal targeting of ceramide-labeled sphingomyelin.
    Levade T; Leruth M; Graber D; Moisand A; Vermeersch S; Salvayre R; Courtoy PJ
    J Lipid Res; 1996 Dec; 37(12):2525-38. PubMed ID: 9017505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysosomal involvement in cellular turnover of plasma membrane sphingomyelin.
    Sutrina SL; Chen WW
    Biochim Biophys Acta; 1984 Apr; 793(2):169-79. PubMed ID: 6424713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake and degradation of several pyrenesphingomyelins by skin fibroblasts from control subjects and patients with Niemann-Pick disease. Effect of the structure of the fluorescent fatty acyl residue.
    Levade T; Gatt S; Salvayre R
    Biochem J; 1991 Apr; 275 ( Pt 1)(Pt 1):211-7. PubMed ID: 2018477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of pyrenesulfonylamido-sphingomyelin and its use as substrate for determining sphingomyelinase activity and diagnosing Niemann-Pick disease.
    Klar R; Levade T; Gatt S
    Clin Chim Acta; 1988 Sep; 176(3):259-67. PubMed ID: 2846208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An enzymatic assay for quantifying sphingomyelin in tissues and plasma from humans and mice with Niemann-Pick disease.
    He X; Chen F; Gatt S; Schuchman EH
    Anal Biochem; 2001 Jun; 293(2):204-11. PubMed ID: 11399033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creation of a mouse model for non-neurological (type B) Niemann-Pick disease by stable, low level expression of lysosomal sphingomyelinase in the absence of secretory sphingomyelinase: relationship between brain intra-lysosomal enzyme activity and central nervous system function.
    Marathe S; Miranda SR; Devlin C; Johns A; Kuriakose G; Williams KJ; Schuchman EH; Tabas I
    Hum Mol Genet; 2000 Aug; 9(13):1967-76. PubMed ID: 10942425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake and metabolism of radioactively labeled sphingomyelin in cultured skin fibroblasts from controls and patients with Niemann-Pick disease and other lysosomal storage diseases.
    Kudoh T; Velkoff MA; Wenger DA
    Biochim Biophys Acta; 1983 Nov; 754(1):82-92. PubMed ID: 6626569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage uptake of oxidized LDL inhibits lysosomal sphingomyelinase, thus causing the accumulation of unesterified cholesterol-sphingomyelin-rich particles in the lysosomes. A possible role for 7-Ketocholesterol.
    Maor I; Mandel H; Aviram M
    Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1378-87. PubMed ID: 7670952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction of sphingomyelinase deficiency in Niemann-Pick type C fibroblasts by removal of lipoprotein fraction from culture media.
    Thomas GH; Tuck-Muller CM; Miller CS; Reynolds LW
    J Inherit Metab Dis; 1989; 12(2):139-51. PubMed ID: 2547109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and expression of five mutations in the human acid sphingomyelinase gene causing types A and B Niemann-Pick disease. Molecular evidence for genetic heterogeneity in the neuronopathic and non-neuronopathic forms.
    Takahashi T; Suchi M; Desnick RJ; Takada G; Schuchman EH
    J Biol Chem; 1992 Jun; 267(18):12552-8. PubMed ID: 1618760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retroviral-mediated transfer of the human acid sphingomyelinase cDNA: correction of the metabolic defect in cultured Niemann-Pick disease cells.
    Suchi M; Dinur T; Desnick RJ; Gatt S; Pereira L; Gilboa E; Schuchman EH
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3227-31. PubMed ID: 1565614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructural investigations on two lymphoid cell lines from Niemann-Pick disease type B.
    Bes JC; Salvayre R; Levade T; Caratero C; Planel H
    Biol Cell; 1984; 50(3):299-302. PubMed ID: 6087964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.